Japan
Kyowa Kirin Co., Ltd. is a seasoned player in the pharmaceutical industry with over 70 years of experience in drug discovery and biotechnology innovation. The company strives to discover novel medicines that can bring significant value to patients' lives, particularly those suffering from severe or rare diseases.
As a Japan-based Global Specialty Pharmaceutical Company, Kyowa Kirin focuses on engineering the next generation of antibodies and developing cell and gene therapies. Their commitment extends across four key regions: Japan, Asia Pacific, North America, and EMEA/International, emphasizing sustainable growth and shared values.
Although details regarding the founding year, headquarters, and past investors are not specified, Kyowa Kirin's long-standing presence and focus on innovative therapies make it a compelling opportunity for investment considerations. Their expertise in specialized pharmaceuticals positions them well to address unmet medical needs and potentially achieve significant market impact.
